Jamiri, Baby Girl -.
HRN: 21-28-74 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/27/2022
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
04/27/2022
05/04/2022
IV
36mg
Q24
Pcap C
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes